Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
-
Diamondback Energy, Inc. Schedules Fourth Quarter 2025 Conference Call for February 24, 2026
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2025 Conference Call for February 24, 2026
-
Genelux Corporation Announces Proposed Public Offering of Common Stock
-
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Art Technology Acquisition Corp. Announces the Closing of $220 Million Initial Public Offering
-
Crane Harbor Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 12, 2026
-
Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq
-
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
-
Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026
-
Pure Cycle Announces Financial Results for the Three Months Ended November 30, 2025
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
-
Bahamas.com Wins Caribbean’s Best Tourism Authority Website 2025 at World Travel Tech Awards
-
Nyack Welcomes Rockland’s First LaserTattoo Removal Clinic: Brief Tattoo Removal, with a Promotional Event on January 15
-
On One-Year Anniversary of California Wildfires, SBA Extends Disaster Relief Deadlines as Local Bureaucrats Stall Recovery
-
CAROLE ROBERTSON CENTER FOR LEARNING MARKS 50 YEARS OF SERVICE
-
The USO Announces Seven New Members Elected to USO Board of Governors
-
Angle Advisors announces GKN Powder Metallurgy has sold Forecast 3D to ADDMAN Engineering, LLC, a portfolio company of American Industrial Partners
-
Senior Simon App Takes Hold at American House, Setting a New Benchmark for Senior Living Communication
-
L’Oréal successfully prices a 1.750 billion euro triple tranche bond
-
MyFitnessPal Launches App in New ChatGPT Health Experience
-
MyFitnessPal Launches App in New ChatGPT Health Experience
-
The Great Courses Journeys - New Educational Travel for the Curious Traveler
-
Liberty Military Housing Promotes Jasmine Alarcon to Regional Vice President of Southwest Marines
-
BEFORE THE X50 CAME HYTE’S Z90 IMPOSSIBLE AIRFLOW CASE: A CONCEPT THAT DARED TO REACH THE ZENITH OF MODERN DESIGN AND COOLING – LEARN MORE AT CES 2026
-
Axalta Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
-
M2i Global, along with Volato Group, and Titanium X Sign Strategic Collaboration Agreement to Advance Critical Mineral Development in the United States
-
HyperCharge Health issues new statement calling for increased attention on Minnesota's Lyme Disease Crisis
-
The Tech Interactive Honors Steve Wozniak With James C. Morgan Global Humanitarian Award
-
End of Day Message
-
Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis
-
Weekly share repurchase program transaction details
-
Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody
-
Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody
-
RedTeam Announces Offline Mode for RedTeam Go Mobile App
-
Headwall Appoints Chief Product Officer and Chief Marketing Officer
-
Pinnacle Treatment Centers Appoints Brian Lantier as Chief Executive Officer
-
Rent with Clara Launches Multi-Layer Bank Verification to Combat Rising Rental Application Fraud
-
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
-
Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize
-
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
-
THEON completes the acquisition of a circa 9.8% stake in Exosens
-
UPDATE - Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option
-
Upper Deck Announces Coveted Harry Potter License, Upcoming Product Collection
-
Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
-
Achievement of the 2025 target for operating and construction capacity of 3.6 gigawatts
-
Asia Forex Mentor Announces AFM Trading Summit Live 2026 – A Free Flagship Global Online Event Setting the 2026 Playbook for Traders and Investors
-
Transaction in Own Shares
-
SIA and Bullhorn Announce New IT Staffing Indicator
-
THE CHOKE POINT: 5 Assets That Control the Bottleneck
